Katarina Nikolic

A perspective on multi-target drug discovery and design for complex diseases

Rona R. Ramsay, Marija R. Popovic-Nikolic, Katarina Nikolic, 2018, Clinical and Translational Medicine.

Rational drug design of antineoplastic agents using 3D-QSAR, cheminformatic, and virtual screening approaches.

John B. O. Mitchell, Katarina Nikolic, Jelica Vucicevic, 2019, Current medicinal chemistry.

Application of mathematical modeling for the development and optimization formulation with bioactive copper complex

Katarina Nikolic, Milorad Cakic, Danica Agbaba, 2013, Drug development and industrial pharmacy.

QSAR study of α-tocopherol derivatives with chemotherapeutic activity against human breast cancer cells

Katarina Nikolic, K. Nikolić, 2007 .

Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids

Katarina Nikolic, Isabel Iriepa, Elena Soriano, 2014, Drug design, development and therapy.

Prediction of hepatic microsomal intrinsic clearance and human clearance values for drugs.

Katarina Nikolic, K. Nikolić, Danica Agababa, 2009, Journal of molecular graphics & modelling.

N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor.

Stefano Alcaro, Katarina Nikolic, Francesco Ortuso, 2014, Journal of medicinal chemistry.

One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug

Rona R. Ramsay, Katarina Nikolic, K. Nikolić, 2016, Front. Neurosci..